Plaque Psoriasis

These data allow for a basis for additional research and possible interventions to address psoriasis patients’ demodicosis risk.

Experts conclude the series discussing how to approach switching psoriasis treatments.

Experts discuss package warnings associated with bimekizumab and how they inform patients of them.

Experts discuss bimekizumab for the treatment of psoriasis highlighting is efficacy over other treatments.

Dermatologists Drs Tina Bhutani and Scott Boswell and a patient share resources and tools available to cope with generalized pustular psoriasis (GPP).

Dermatologists Drs Tina Bhutani and Scott Boswell and a patient share resources and tools available to cope with generalized pustular psoriasis (GPP).

A patient and 2 dermatologists discuss the impact of generalized pustular psoriasis (GPP) on patient’s quality of life.

A new study found intensive topical therapy improves deep sleep and REM sleep for patients with psoriasis and atopic dermatitis after 2 weeks.

A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.

Experts emphasize the importance of collaboration with infectious disease specialists for patients with tuberculosis, while highlighting the low reactivation rates in newer agents.

Dermatologists Drs Tina Bhutani and Scott Boswell and a patient discuss unpredictable nature of generalized pustular psoriasis (GPP) and management of flares and GPP between flares.

Dermatologists Drs Tina Bhutani and Scott Boswell discuss use of spesolimab to treat generalized pustular psoriasis (GPP) flares.

In this analysis, investigators sought to assess PsA development probability in subclinical PsA as well as to characterize symptoms and patterns of subclinical PsA.

In this analysis, the study investigators highlighted the impact of smoking cigarettes on PASI 75 achievement.

Experts highlight how a history of cancer may impact psoriasis treatment decisions while touching on the safety profiles of newer IL agents.

Experts discuss common comorbidities for patients with plaque psoriasis and how they can impact treatment decisions.

These data highlight guselkumab’s impact on psoriasis patients’ symptoms and HRQoL, as well as on sexual impairment and perceptions of stigmatization.

A patient shares how her generalized pustular psoriasis (GPP) was initially treated and Drs Tina Bhutani and Scott Boswell discuss available treatment options for GPP.

Dr Scott Boswell highlights how he differentiates between generalized pustular psoriasis (GPP) and other dermatologic conditions.

These nationwide data contribute to the overall body of research on extraintestinal inflammatory conditions among MC patients, highlighting the value of studying the mechanisms involved.

Experts discuss the landscape of IL therapies for the treatment of psoriasis, highlighting their improved safety and efficacy over prior agents.

Experts discuss the use of TNF blockers in treating plaque psoriasis and their limited but important uses today.

A patient and dermatologists discuss flare-ups and episodic nature of generalized pustular psoriasis (GPP).

Dermatologists Drs Tina Bhutani and Scott Boswell discuss how patients with generalized pustular psoriasis (GPP) typically present in the hospital.